ptcbio.com

Please wait for loading...




      (34):

    /
     2  ~ 2014 mar 26d best ptcPTC Therapeutics Announces that Stuart W. Peltz, Ph. D ., CEO is the SOUTH PLAINFIELD, NJ – January 30, 2014 – PTC Therapeutics, Inc. (NASDAQ: PTCT) is proud to ... Named for Sol J. Barer, Ph. D ., founder and former Chairman and Chief Executive Officer of ... Close window | Back to top .
     11  ~ 2014 jun 20therapeutics incPTC Therapeutics : HomeFocused on the discovery and commercialization of orally active small molecule therapeutics for human diseases.
     12  +1 2014 may 28ptc indexptc therapeutics added to nasdaq biotechnology indexSOUTH PLAINFIELD, NJ – December 23, 2013 – PTC Therapeutics, Inc. ... The NASDAQ Biotechnology Index is designed to track the ...
     13  -9 2014 jun 05therapeutics
     14  +4 2014 may 22does ptc sense workPTC Therapeutics: Culture and ValuesSENSE OF URGENCY — We do today what can be done today. ... We are committed to our work , strive to consistently meet deadlines and apply pride and  ...
     17  -2 2014 jun 15ptc emailPTC Therapeutics: CareersAt PTC Therapeutics we are looking at drug discovery and development in a whole ... If you are interested in employment with PTC Therapeutics, please email  ...
     22  +8 2014 may 29new ptc'sPTC Therapeutics: HomePTC applies its expertise in RNA biology and drug development to pioneer novel ... Ataluren (PTC124®) is an investigational new drug designed to enable the ...
     24  +43 2014 jun 16ptc wikiPTC Therapeutics: About UsPTC Therapeutics, Inc. ( PTC ) is a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small-molecule ...
     26  +72 2014 apr 10update new ptcptc therapeutics provides update on chmp opinion for conditional PTC THERAPEUTICS PROVIDES UPDATE ON CHMP OPINION FOR ... If an appeal is unsuccessful, the Company could resubmit a new  ...
     29  +57 2014 may 04becker muscular dystrophyAdvanced Duchenne/ Becker Muscular Dystrophy Genetic TestingGenetic Testing for Duchenne and Becker Muscular Dystrophy . Genetic tests find changes, called mutations, in genes that cause disease. These tests can be a ...
     29  ~ 2014 may 03buy ptc websitePTC applies its expertise in RNA biology and drug development to pioneer novel oral treatments for patients living with serious and life-threatening conditions.
     30  -10 2014 may 05ptc phone numberPTC Therapeutics: Location & DirectionsLocation Information PTC Therapeutics Inc. 100 Corporate Court South Plainfield , NJ 07080-2449. Phone :908-222-7000. Fax: 908-222-7231 info@ ptcbio .com.
     32  ~ 2014 apr 23best ptc success planPTC Therapeutics Reports Fourth Quarter and Year-End 2013 We also plan to pursue additional indications for ataluren beyond nmDMD and
     38  -17 2014 may 09ptc en venezuelaPTC Therapeutics: Contact UsIf you would like to subscribe to receive PTC updates, please enter your preferences below: PTC Corporate Updates (All company financial, clinical or research ...
     41  +39 2014 may 30pt c
     43  ~ 2014 apr 03single gene disordersPTC Therapeutics: Genetic DisordersCystic fibrosis is among the most common life-threatening genetic disorders worldwide. Cystic fibrosis is caused by defects in a single gene known as the cystic ...
     47  ~ 2014 jun 15ptc votePTC Therapeutics - Definitive Additional Proxy MaterialsPTC Therapeutics, Inc. Logo ... You can vote only by following the instructions on the reverse side. This communication presents only an ...
     47  -17 2014 may 13american ptc sitesptc therapeutics to present at the north american cystic fibrosis PTC THERAPEUTICS TO PRESENT AT THE NORTH AMERICAN ... For more information, visit the company's web site at www. ptcbio .com.
     50  +2 2014 apr 25ptc site submissionPTC Therapeutics Reports Second Quarter 2013 Financial And The Phase 3 study is expected to be conducted at 53 clinical sites ... In July 2013, PTC submitted responses to the Day 120 Questions to the ...
     52  -12 2014 may 21ptc investigatorPTC Therapeutics: ACT DMD SitesBelow is a list of countries where there is a trial site for the ACT DMD trial. Please expand each country to see a list of the trial sites and contact information for ...
     54  +47 2014 may 24protein synthesis and gene expressionPTC Therapeutics: RNA BiologyThe normal course of gene expression involves the production of RNA by a ... To ensure that the appropriate proteins are always synthesized in the correct cells ...
     58  ~ 2014 apr 30power of ptcPTC Therapeutics - Amended Statement of Beneficial Ownership(a) Amount Beneficially Owned: 3,206,020 (b) Percent of Class: 12.867% (c) Number of shares as to which such person has: (i) sole power to ...
     59  +42 2014 jun 12what is ptc
     60  ~ 2014 may 24royal ptc
     63  ~ 2014 apr 21spinal muscular atrophyjoint program in spinal muscular atrophy enters ... - PTC TherapeuticsJOINT PROGRAM IN SPINAL MUSCULAR ATROPHY ENTERS FIRST STAGE ... SMA is a genetic neuromuscular disorder that leads to muscle ...
     64  -11 2014 apr 05protein synthesis wordThis protein synthesis machinery is capable of sequentially reading each three- letter genetic code " word " in mRNA and converting its respective encrypted ...
     70  -25 2014 may 06press release summaryPTC Therapeutics, Inc. - Press ReleasesThe information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics ... View Summary  ...
     72  ~ 2014 apr 09muscular spinal atrophy
     82  ~ 2014 may 05cowen and companyptc therapeutics to present at the cowen & company 34th annual PTC THERAPEUTICS TO PRESENT AT THE COWEN & COMPANY 34TH ANNUAL HEALTH CARE CONFERENCE ...
     82  ~ 2014 apr 13poc private financingOur private financing early in the year combined with a very ... and expect to initiate a proof-of-concept study for a third indication this year."
     82  +19 2014 mar 24ptc to get leadsPTC Therapeutics: Advanced Duchenne/Becker Muscular Dystrophy Genetic tests find changes, called mutations, in genes that cause disease. ... muscle cells become fragile and break down, and this leads to muscle weakness.
     92  ~ 2014 may 17no minimum ptcPTC Therapeutics: ACT DMD OverviewPTC Therapeutics has initiated a Phase 3 clinical trial of ataluren (formerly ... for a minimum of 6 months immediately prior to the start of the study, with no  ...
     93  -23 2014 apr 15south plainfield websiteFocused on the discovery and commercialization of orally active small molecule therapeutics for human diseases.
     94  ~ 2014 mar 30en iyi ptcPTC Therapeutics: DMD Clinical Trial FAQQ: PTC 'ye Avrupa'da koşullu onay verildiyse, hastalar çalışmaya katılmak yerine ... potansiyel riskleri ve faydaları en iyi şekilde tartacak olan baş araştırmacıdır.
    1 of 1 pages